Author's reply – Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial

• Hideto Yamada,
• Masashi Deguchi,
• Shigeru Saito,
• Toshiyuki Takeshita

Affiliations

Hideto Yamada

Centre for Recurrent Pregnancy Loss, Teine Keijinkai Hospital, 1-40 Maeda 1-jho 12-chome Teine-ku, Sapporo, Japan; Corresponding author at: Director of Centre for Recurrent Pregnancy Loss, Teine Keijinkai Hospital, 1-40 Maeda 1-jho 12-chome Teine-ku, Sapporo 006-8555, Japan.

Masashi Deguchi

Department of Obstetrics and Gynecology, Kobe University School of Medicine, 7-5-1 Kusunoki-cho Chuo-ku, Kobe, Japan

Shigeru Saito

Department of Obstetrics and Gynecology, University of Toyama, 2630 Sugitani, Toyama, Japan

Toshiyuki Takeshita

Department of Obstetrics and Gynecology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, Japan